Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Preferred Stock Liabilities (2018 - 2019)

Exagen's Preferred Stock Liabilities history spans 2 years, with the latest figure at $121.0 million for Q2 2019.

  • For Q2 2019, Preferred Stock Liabilities changed N/A year-over-year to $121.0 million; the TTM value through Jun 2019 reached $121.0 million, changed N/A, while the annual FY2018 figure was $1.5 million, N/A changed from the prior year.
  • Preferred Stock Liabilities reached $121.0 million in Q2 2019 per XGN's latest filing, up from $1.5 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $121.0 million in Q2 2019 to a low of $1.5 million in Q4 2018.